Hjem › Ikke-muskulinvasiv blærecancer › Massachusetts
Kliniske studier for Ikke-muskulinvasiv blærecancer i Massachusetts
10 studier for Ikke-muskulinvasiv blærecancer søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Brigham and Women's Hospital, Boston
- Lahey Clinic, Burlington
- Lahey Clinic Peabody, Peabody
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Greater Boston Urology, Plymouth
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Greater Boston Urology, Plymouth
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06919965Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- VA Boston Jamaica Plains Campus, West Roxbury
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05796375Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Brigham and Women's Hospital, Boston
- Greater Boston Urology, LLC, Plymouth
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Massachusetts General Hospital, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05519241LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Brigham and Women's Hospital, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- Brigham and Women's Hospital, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT05710848Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
- Lahey Hospital and Medical Center, Burlington
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2025 · NCT07187063Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.